AU Patent

AU2014259750B2 — Conjugated antisense compounds and their use

Assigned to Ionis Pharmaceuticals Inc · Expires 2019-02-28 · 7y expired

What this patent protects

Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to

USPTO Abstract

Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to

Drugs covered by this patent

Patent Metadata

Patent number
AU2014259750B2
Jurisdiction
AU
Classification
—
Expires
2019-02-28
Drug substance claim
No
Drug product claim
No
Assignee
Ionis Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.